These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
1,488 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
C.R. Bard recalled 4,300 Foley catheter trays on July 17, 2025. Incorrect inserts may lead users to misidentify materials, increasing infection and allergic reaction risks. Patients and healthcare providers must stop using the trays immediately and follow recall instructions.
DermaRite Industries recalled 5,703 bottles of PeriGiene antiseptic on July 17, 2025. The product contains Burkholderia cepacia, posing health risks. Consumers must stop using the product immediately.
DermaRite Industries LLC recalled 249 bottles of DermaSarra External Analgesic on July 17, 2025. The product contains camphor and is contaminated with Burkholderia cepacia. This recall is classified as Class I due to the potential health risks.
C.R. Bard recalled 3,670 Foley catheter trays on July 17, 2025, due to incorrect inserts. Users may confuse materials, leading to allergies or infections. Healthcare providers and patients must stop using these trays immediately.
DermaRite Industries LLC recalled 11,321 bags of DermaKleen antiseptic lotion soap on July 17, 2025. The product, contaminated with Burkholderia cepacia, poses a serious health risk. Consumers should stop using the product immediately and contact health providers for guidance.
iStore recalled 5,000 Magnetic Wireless Power Banks on July 17, 2025. The recall affects model IST-09991/W05 due to overheating and fire hazards. Consumers should stop using the devices immediately and seek a refund.
Quest International recalled 376 Measles IgM Test Kits on July 17, 2025. The kits lack premarket approval or clearance from the FDA. Healthcare providers and patients must stop using these kits immediately.
Stryker Communications recalled 40 surgical light systems on July 15, 2025, due to potential powder coating chipping. This defect increases risks for healthcare providers and patients. Affected products were distributed nationwide, including Texas, Illinois, and New York.
WLIVE recalled its 15-drawer fabric dressers on July 10, 2025. The recall affects models that pose tip-over and entrapment hazards. Consumers should stop using these dressers immediately if not anchored to a wall.
AUGNORYE recalled padded crib bumpers on July 10, 2025, after reports of suffocation hazards. The bumpers violate federal safety regulations. Consumers should stop using them immediately and request a refund.
Biofire Defense recalled 130 kits of the FilmArray NGDS Warrior Panel on July 10, 2025. The recall is due to an increased risk of internal control failures when testing positive blood cultures. These failures could delay results and require additional diagnostic workups.
Dearlomum recalled retractable safety gates on July 10, 2025. The gates pose a serious entrapment hazard to children, potentially leading to injury or death. About 10,000 units were sold on Amazon and other retailers.
SPPTTY recalled kids bicycles on July 10, 2025, due to lead poisoning risks. The bicycles exceed federal lead content limits, posing serious health hazards to children. Consumers should stop using the bicycles and seek refunds immediately.
Haoyunm recalled braided crib bumpers on July 10, 2025, due to suffocation hazards. The crib bumpers violate federal safety regulations. Consumers should stop using them immediately and seek a refund.
Boothwyn Pharmacy recalled 642 vials of Semaglutide injection on July 9, 2025. The recall follows the discovery that the drug is subpotent. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Boothwyn Pharmacy recalled 8 vials of Fluorescein 2% Ophthalmic Solution on July 9, 2025. The recall occurred due to the drug being subpotent, posing potential health risks. Consumers should stop using the product immediately and seek guidance from their healthcare provider.
Boothwyn Pharmacy recalled 186 vials of Semaglutide, 2.5 mg/mL injection on July 9, 2025. The product is subpotent and poses a risk to consumers. Healthcare providers and consumers should stop using this product immediately.
Boothwyn Pharmacy recalled 648 vials of Semaglutide injection on July 9, 2025. The product is subpotent and poses a high hazard risk. Consumers should stop using the product immediately and contact their healthcare provider.
Boston Scientific Neuromodulation recalled 25,260 deep brain stimulation systems on July 8, 2025, due to wire break issues. Users may experience loss of therapy and other serious complications. Patients should stop using the devices immediately and seek further instructions.
CURAD recalled 1,639,996 alcohol prep pads on July 7, 2025. The recall addresses subpotent isopropyl alcohol levels that fall below labeled concentration. Consumers should stop using these products immediately.